The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of olaparib (ola) plus abiraterone (abi) versus placebo (pbo) plus abi in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with a germline or somatic BRCA mutation in the PROpel trial.
 
Fred Saad
Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Tolmar
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi; Tolmar
Research Funding - Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Andrew Armstrong
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Bristol-Myers Squibb; Cytogen; Exelixis; GoodRx; Janssen; Merck; Myovant Sciences; Novartis; Pfizer
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Syntrix Biosystems (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc
 
Mototsugu Oya
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol Myers Squibb Foundation; Novartis; Ono Pharmaceutical; Pfizer; Takeda
Consulting or Advisory Role - Bayer
Research Funding - Novartis; Pfizer
 
Neal Shore
Employment - GenesisCare
Consulting or Advisory Role - Accord Research; Alessa Therapeutics; Amgen; Antev; Arquer Diagnostics; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Aura Biosciences; Bayer; Bioprotect; Bristol-Myers Squibb/Sanofi; CG Oncology; Clarity Pharmaceuticals; Dendreon; Exact Imaging; Ferring; Fize Medical; Glytherix; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myriad Genetics; Novartis; Peerview; Pfizer; Photocure; PlatformQ Health; Promaxo; Propella Therapeutics; Protara Therapeutics; Sanofi; Siemens; Speciality Networks; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar; Tutelix; Urogen pharma
Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow
 
Cagatay Arslan
No Relationships to Disclose
 
Karina Vianna
Consulting or Advisory Role - Adium Pharma; AstraZeneca; Roche/Genentech
Speakers' Bureau - AstraZeneca; Bayer; BMS Brazil; GlaxoSmithKline; Knight Pharmaceuticals; Pfizer; Roche/Genentech; SERVIER
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb Brazil (Inst); Janssen Oncology (Inst); Lilly (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Roche/Genentech
 
Gary Buchschacher
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Merck (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline (Inst)
 
Craig Gedye
No Relationships to Disclose
 
Emma Brown
Consulting or Advisory Role - Sciensus
 
Urban Emmenegger
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; Pfizer
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen; Knight Therapeutics; Merck; Pfizer
Research Funding - Astellas Pharma; Bayer; Janssen
 
Friederike Schlürmann
Honoraria - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer
 
Ji Youl Lee
No Relationships to Disclose
 
Jae Young Joung
No Relationships to Disclose
 
Mustafa Özgüroglu
Honoraria - Astellas Pharma; Janssen; Novartis; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Janssen; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Bristol Myers Squibb Foundation; Janssen
 
Elizabeth Harrington
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Alan Barnicle
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
David McGuinness
Employment - AstraZeneca
 
Arnold Degboe
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Christian Hosius
Employment - MSD Oncology
Stock and Other Ownership Interests - MSD Oncology
 
Noel Clarke
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Ferring; ipsen; Janssen-Cilag; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Janssen-Cilag; Sanofi
Speakers' Bureau - Astellas Pharma; Astellas Pharma; AstraZeneca; Janssen-Cilag; Janssen-Cilag
Research Funding - AstraZeneca; Astrazeneca (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi